September 2026
The psychedelic API market reached USD 5.47 billion in 2026, with key psychedelic API market companies including Compass Pathways, MindMed (Mind Medicine Inc.), Atai Life Sciences.
September 2026
The telecom API market size is valued at USD 371.05 billion in 2026 and is projected to surge around USD 2,011.56 billion by 2035 with a CAGR of 20.73%.
September 2026
The 3D rapid liquid printing market size is expected to hit around USD 1,364.68 million by 2034 from USD 274.45 million in 2026, with a notable CAGR of 22.20%.
September 2026
The global landscaping products market size reached USD 100.93 billion in 2026 and is projected to surpass around USD 170.46 billion by 2034, with a notable CAGR of 6.76%.
September 2026
The global plant-based API market size is calculated at USD 38.63 billion in 2026 and is projected to hit around USD 67.39 billion by 2035 with a CAGR of 6.38%.
September 2026
The global capillary blood collection devices market size is projected to surpass around USD 3.74 billion by 2034 increasing from USD 2.44 billion in 2026, with a CAGR of 5.49%.
September 2026
The global oral cancer rapid test kit market size is estimated to hit around USD 3.94 billion by 2035 increasing from USD 2.50 billion in 2026, with a CAGR of 5.17%.
September 2026
The global network API market size is projected to surpass around USD 90.30 billion by 2035 increasing from USD 3.30 billion in 2026, with a CAGR of 44.66%.
September 2026
The global small molecule API market size was valued at USD 217 billion in 2026 and is projected to surpass around USD 347.45 billion by 2035 with a CAGR of 5.38%.
September 2026
The global peptide api market size is estimated to hit around USD 100.16 billion by 2035, increasing from USD 65.08 billion in 2026, with a CAGR of 4.91%.
September 2026
The rapid microbiology testing market size was USD 7.37 billion in 2026, with leading rapid microbiology testing market players including Creative Diagnostics, bioMérieux, Synbiosis, Thermo Fisher Scientific,
September 2026
The RNA editing therapies market expands with clinical progress in precision therapeutics, rare disease solutions, and gene-based medicine.
September 2026
The global rapid prototyping market size is calculated at USD 4.83 billion in 2026 and is projected to hit around USD 24.71 billion by 2035 with a CAGR of 19.94%.
September 2026
The global human capital management market size is projected to surpass around USD 81.41 billion by 2035 from USD 34.37 billion in 2025 with a notable CAGR of 9.01%%.
September 2026
The cosmeceutical API market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
September 2026
The global pharmaceutical rapid microbiology testing market size is estimated to hit around USD 6.40 billion by 2035 from USD 1.32 billion in 2025, with a CAGR of 17.10%.
September 2026
The global oral obesity therapies market size was evaluated at USD 4.70 billion in 2026 and is predicted to hit around USD 9.34 billion by 2035, growing at a CAGR of 7.94%.
September 2026
The global microbial API market size was valued at USD 62.66 billion in 2024 and is projected to surpass around USD 108.59 billion by 2034, with a CAGR of 5.65%.
September 2026
The b-cell maturation antigen (BCMA) targeted therapies market size reached USD 6.62 billion in 2026, with leading B-Cell Maturation Antigen (BCMA) Targeted Therapies Market companies including Bristol Myers Squibb, Johnson & Johnson, GSK plc, Amgen Inc., Regeneron Pharmaceuticals, Inc.
September 2026
The chemical API CDMO market size was USD 18.36 billion in 2026, with leading chemical API CDMO market players including Lonza Group, WuXi AppTec, Samsung Biologics, Boehringer Ingelheim.
September 2026
The CAR-T therapies for blood cancers market generated USD 8.09 billion in 2026, with prominent CAR-T therapies for blood cancers market companies including Novartis AG, Gilead Sciences, Inc. (Kite Pharma), Bristol Myers Squibb Company (Celgene/Juno Therapeutics), Johnson & Johnson (Legend Biotech Corporation).
September 2026
The U.S. radiopharmaceutical therapies market size is estimated to hit around USD 7.70 billion by 2035 increasing from USD 1.92 billion in 2025, with a CAGR of 14.9%%.
August 2026
The autologous stem cell and non-stem cell based therapies market size stood at USD 10.75 billion in 2026, with major autologous stem cell and non-stem cell based therapies market companies including Vericel Corporation, Holostem Terapie Avanzate, Anterogen Co. Ltd., BrainStorm Cell Therapeutics.
August 2026
The high-potency API (HPAPI) CDMO market is expanding with rising demand for oncology drugs, targeted therapies, and advanced containment solutions.
July 2026
API Security and Management Market grows with digital integration, zero-trust security models, and rising API-based applications.
June 2026
The global synthetic small molecule API market size is estimated to hit around USD 342.63 billion by 2035 increasing from USD 208.51 billion in 2026, with a CAGR of 5.68%.
June 2026
The rapid diagnostics market size was estimated at USD 51.12 billion in 2025 and is projected to surpass around USD 322.71 billion in 2035 with a solid CAGR of 20.23%.
June 2026
The global psychedelic therapeutics market size is estimated to hit around USD 12.40 billion by 2035 increasing from USD 2.94 billion in 2025, with a CAGR of 15.48%.
May 2026
The global peptide therapeutics contract API manufacturing market size is estimated to hit around USD 9.02 billion by 2035 from USD 4.19 billion in 2026, at a CAGR of 9.02%.
May 2026
The global healthcare API market size is projected to hit around USD 348.4 million by 2035 from USD 243.56 million in 2025, growing at a CAGR of 3.64%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com